- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03748121
Yoga/Pranayama for Posttraumatic Stress Disorder (YOGAPTSD)
December 5, 2022 updated by: Heidemarie Haller, Universität Duisburg-Essen
Pranayama Assisted Psychotherapy in Patients With Post-traumatic Stress Disorder: a Randomized-controlled Trial
This study aims to investigate the effect of a pranayama focused yoga intervention on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard psychotherapy/ trauma-focused cognitive-behavioral therapy (TF-CBT).
Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of standard TF-CBT unit, while the control group will get standard TF-CBT alone.
It should further be investigated, whether pranayama can enhance the affective tolerance of patients with post-traumatic stress disorder towards the used exposure techniques of TF-CBT.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NRW
-
Neuss, NRW, Germany, 41460
- Dietmar Mitzinger
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed PTSD according to ICD-10
- PCL-5 Score of at least 33 points
- Undergoing outpatient CBT
- Physical and mental ability to perform Pranayama
Exclusion Criteria:
- Severe comorbid mental or somatic disease that did not allow the patient to perform Pranayama
- Pregnancy
- Regular practice of Yoga or Pilates in the last 12 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pranayama assisted Trauma-focused Cognitive Behavioral Therapy (TF-CBT)
To prepare patients for the TF-CBT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-CBT units.
|
The pranayama intervention is placed directly at the begin of the respective TF-CBT unit and will be repeated for 10 subsequent TF-CBT units.
Pranayama contains the performance of Kapalabhati, Ujjayi, and/or Nadi Shodhana (for overall 1 minute) as well as following Kumbhaka (intentional respiratory reflex inhibition).
Pranayama will be repeated 3 times before each TF-CBT unit.
|
Active Comparator: Trauma-focused Cognitive Behavioral Therapy (TF-CBT)
Patients wait for 10 TF-CBT units and then are offered to learn pranayama.
|
Trauma-focused Cognitive Behavioral Therapy (TF-CBT)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intensity of posttraumtic symptoms
Time Frame: week 10
|
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points.
The cut-off point for clinically relevant symptom severity is 33 points.
|
week 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health-related quality of life
Time Frame: week 10
|
Short Form 12 Health Survey (SF-12): The SF-12 is a standard 12-item scale with two sum scores (physical and mental quality of life) ranging from 0 to 100 points.
|
week 10
|
Ability of social participation
Time Frame: week 10
|
Patient-Reported Outcomes Measurement Information System - Ability to Participate in Social Roles and Activities Scale (PROMIS): The PROMIS-Social Participation Subscale is a standard 8-item scale ranging from 0 to 100 points with 100 points represent the highest possible ability to participate/function.
|
week 10
|
Anxiety
Time Frame: week 10
|
Beck Anxiety Inventory (BAI): The BAI is a standard 21-items scale ranging from 0 to 63 points with 0-7 points = minimal anxiety, 8-15 points = mild anxiety, 16-25 points = moderate anxiety, and 26-63 points = clinically relevant anxiety.
|
week 10
|
Depression
Time Frame: week 10
|
Beck Depression Inventory Revision (BDI-II): The BDI-II is a standard 21-items scale ranging from 0 to 63 points with 0-13 points =no/clinically not relevant depression/depression in remission, 14-19 points = mild depression, 20-28 points = moderate depression und 29-63 points = severe depression.
|
week 10
|
Distress Tolerance
Time Frame: week 10
|
Distress Tolerance Scale (DTS): The DTS is a standard 15-item scale ranging from 0 to 75 points.
Higher scores represent higher distress tolerance.
|
week 10
|
Emotion Regulation
Time Frame: week 10
|
Emotion Regulation Scale (ERQ): The ERQ is a standard 10-item scale with 6 items are added to the Cognitive Reappraisal subscale ranging from 6 to 42 and 4 items are added to the Expressive Suppression subscale ranging from 4 to 28.
Higher scores on the Cognitive Reappraisal subscale and lower ones on the Expressive Suppression subscale represent a better regulation of emotions.
|
week 10
|
Body Awareness
Time Frame: week 10
|
Scale of Body Connection (SBC): The SBC is a standard 20-items scale ranging from 0 to 80 that contains two subscales: Body Awareness and Body Dissociation.
Higher scores on Body Awareness and lower scores on Body Dissociation represent a better body awareness.
|
week 10
|
Breath Holding Duration
Time Frame: week 10
|
Breath Holding Task (BHT): The BHT is standard test procedure for the measurement of ability of the suppression of the respiratory reflex.
In PTSD patients, it is associated with distress tolerance.
|
week 10
|
Acute Emotional Stress
Time Frame: week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
Emotional Stress Reaction Questionnaire (ESRQ): The ESRQ is standard 14-items scale ranging from -21 points (predominance of negative emotions) to +21 points (predominance of positive emotions).
Patients received the ESRQ before and after each CBT unit.
|
week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
Adverse Events
Time Frame: week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
Number of patients with adverse events (and type of the adverse event)
|
week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Expectation
Time Frame: week 0
|
Treatment Credibility Scale (TCS): The TCS is a standard NRS scale ranging from 0 points (lowest expectation of treatment effectiveness) to 10 points (highest expectation of treatment effectiveness).
|
week 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Gustav Dobos, Prof. MD, University of Duisburg-Essen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2018
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
July 31, 2020
Study Registration Dates
First Submitted
November 16, 2018
First Submitted That Met QC Criteria
November 19, 2018
First Posted (Actual)
November 20, 2018
Study Record Updates
Last Update Posted (Estimate)
December 6, 2022
Last Update Submitted That Met QC Criteria
December 5, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-7703-BO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
Upon reasonable request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
-
Yale UniversityNational Center for PTSDCompletedPosttraumatic Stress Disorder (PTSD)United States
Clinical Trials on Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT)
-
Norwegian Center for Violence and Traumatic Stress...Recruiting
-
Stanford UniversityNational Institute of Mental Health (NIMH)CompletedEmotions | Memory Deficits | Post-traumatic SyndromeUnited States
-
Johns Hopkins Bloomberg School of Public HealthUnknownDepression | Post Traumatic Stress Disorder | Risk BehaviorsZambia
-
Norwegian Center for Violence and Traumatic Stress...Ministry of Health and Care Services, NorwayCompletedPTSD | Trauma | Mental Health Disorder | ImplementationNorway
-
Queen's University, BelfastCompletedDepression | Conduct Disorder | Post-traumatic Stress Disorder
-
Norwegian Center for Violence and Traumatic Stress...Completed
-
University of UlmGerman Federal Ministry of Education and ResearchCompletedPost-Traumatic Stress DisorderGermany
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedHIV/AIDS | Substance UseUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedPost-Traumatic Stress DisorderUnited States
-
NYU Langone HealthSubstance Abuse and Mental Health Services Administration (SAMHSA)Recruiting